M&A Deal Summary

Merck Acquires ArQule

On December 9, 2019, Merck acquired life science company ArQule for 2.7B USD

Acquisition Highlights
  • This is Merck’s 19th transaction in the Life Science sector.
  • This is Merck’s 8th largest (disclosed) transaction.
  • This is Merck’s 17th transaction in the United States.
  • This is Merck’s 5th transaction in Massachusetts.

M&A Deal Summary
Date 2019-12-09
Target ArQule
Sector Life Science
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 2.7B USD
Advisor(s) Centerview Partners (Financial)
Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

ArQule

Burlington, Massachusetts, United States
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. ArQule's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to human cancers. ArQule was formed in 1993 and is based in Burlington, Massachusetts.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Rahway, New Jersey, United States
Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 60.1B USD (2023)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.

DEAL STATS #
Overall 22 of 35
Sector (Life Science) 19 of 32
Type (Add-on Acquisition) 22 of 33
State (Massachusetts) 5 of 8
Country (United States) 17 of 27
Year (2019) 4 of 4
Size (of disclosed) 8 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-10 Tilos Therapeutics

Lexington, Massachusetts, United States

Tilos Therapeutics, Inc. is a biopharmaceutical company developing therapeutics targeting the latent TGFβ complex for the treatment of cancer, fibrosis and autoimmune diseases. Tilos Therapeutics, Inc. is based in Lexington, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-12 StayWell

Yardley, Pennsylvania, United States

Staywell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. Staywell was founded in 1978 and is headquartered in St. Paul, Minnesota.

Sell -
Mergr

Product

Company

Legal